Frontlight ResearchEarly access
Trial site
The Cancer Institute Hospital of JFCR
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Cervical cancer3 trials
- Head and neck cancer3 trials
- Metastatic breast cancer3 trials
- Ovarian cancer3 trials
- Triple-negative breast cancer3 trials
- Bladder cancer2 trials
- Gastric and oesophageal cancer2 trials
- Pancreatic cancer2 trials
- Prostate cancer2 trials
- Diabetic neuropathy1 trial
- Endometrial cancer1 trial
- Phase
- Phase 14 trials
- Phase 1/22 trials
- Phase 32 trials
- Phase 21 trial
- Status
- Active, not recruiting5 trials
- Recruiting3 trials
- Completed1 trial
- Lead sponsor
- Eli Lilly and Company7 trials
- Gilead Sciences2 trials
Running trials
Recruiting
Active, not recruiting
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Recruiting
Active, not recruiting
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
Recruiting
Active, not recruiting
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Active, not recruiting
Active, not recruiting
Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Cervical cancer2 recruiting
- Head and neck cancer2 recruiting
- Lung cancer2 recruiting
- Ovarian cancer2 recruiting
- Bladder cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026